News
PARSIPPANY, New Jersey, June 7, 2017 /PRNewswire/ --Ascensia Diabetes Care today announced the commercial launch by Medtronic of the MiniMed® 670G ...
The Contour Next One is a smart blood glucose monitor. ... Ascensia claims that the Contour Next One system meets the minimum accuracy requirements of the ISO 15197:2013 standard.
Release Summary. Ascensia Diabetes Care announce that their new state-of-the-art CONTOUR™ NEXT ONE and CONTOUR™ PLUS ONE blood glucose meters, and CONTOUR® Diabetes App, have received CE Mark ...
MISSISSAUGA, ON, Oct. 17, 2018 /CNW/ - Ascensia Diabetes Care today announced the receipt of an amended license from Health Canada for the CONTOUR ® NEXT LINK 2.4 blood glucose meter to be used ...
Ascensia Diabetes Care’s Contour Diabetes app — a mobile tool to monitor trends in blood glucose levels that connects to the Contour Next One glucometer — has received yet another update. As of Monday ...
Under the partnership, the pair will integrate Ascensia’s Contour Next One and Contour Plus One systems into Glooko’s platform. The goal is to improve diabetes data management and analytics ...
2 Bailey TJ et al. Accuracy, Precision, and User Performance Evaluation of the CONTOUR® NEXT LINK 2.4. SOURCE Ascensia Diabetes Care. please contact: Genevieve Brown, 416-254-4154.
Today Ascensia Diabetes Care UK launched the latest version of its Contour Diabetes app, a tool that helps people self-manage their diabetes, in the UK and Ireland. The app is designed to connect to ...
Ascensia Diabetes Care today announced it has entered into a strategic alliance by signing a development agreement with Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump ...
Today, Ascensia Diabetes Care announced that it has received CE Mark (Conformité Européenne) for the new CONTOUR™ NEXT ONE and CONTOUR™ PLUS ONE blood glucose monitoring systems, the next ...
BASEL, Switzerland, June 8, 2017 /PRNewswire/ -- Ascensia Diabetes Care today announced it has entered into a strategic alliance by signing a development agreement with Insulet Corporation (NASDAQ: ...
Today, Ascensia Diabetes Care announced that it has received CE Mark (Conformité Européenne) for the new CONTOUR™ NEXT ONE and CONTOUR™ PLUS ONE blood glucose monitoring systems, the next ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results